Jacobson Pharma Corporation Limited

2633

KYG677291067

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 09:08:42 28/06/2024 BST			5-day change	1st Jan Change
0.65 ^HKD	+1.56%		+1.56%	+1.56%

06-21	Jacobson Pharma's Fiscal Year 2024 Profit, Revenue Rise	MT
06-20	Jacobson Pharma Corporation Limited Proposes the Final Dividend for the Year Ended 31 March 2024 Payable on 04 October 2024	CI

Jacobson Pharma Corporation Limited Proposes the Final Dividend for the Year Ended 31 March 2024 Payable on 04 October 2024

June 20, 2024 at 01:58 pm

Jacobson Pharma Corporation Limited proposed the Final Dividend of HKD 0.03 per share for the Year Ended 31 March 2024 payable on 04 October 2024. Ex-dividend date is on 03 September 2024. Record date is on 06 September 2024.

Date of shareholders' approval is on 28 August 2024.

Latest news about Jacobson Pharma Corporation Limited

Jacobson Pharma's Fiscal Year 2024 Profit, Revenue Rise	06-21	MT
Jacobson Pharma Corporation Limited Proposes the Final Dividend for the Year Ended 31 March 2024 Payable on 04 October 2024	06-20	CI
Jacobson Pharma Corporation Limited Reports Earnings Results for the Full Year Ended March 31, 2024	06-20	CI
Jacobson Pharma Raises HK$39 Million from Share Placement	02-27	MT
Jacobson Pharma Reports 42% Fiscal H1 Profit Growth; Shares Rise	11-24	MT
Jacobson Pharma Corporation Limited Reports Earnings Results for the Half Year Ended September 30, 2023	11-24	CI
Jacobson Pharma Corporation Limited Announces Interim Dividend for the Six Months Ended September 30, 2023, Payable on 10 January 2024	11-24	CI
JBM (Healthcare), Jacobson Pharma Shares Rise on M&A Deal	04/10/23	MT
Jacobson Pharma Corporation Declares A Final Dividend for the Year Ended 31 March 2023	01/08/23	CI
Jacobson Pharma's Dividend Shrinks Despite Surge in FY23 Net Profit	16/06/23	MT
Jacobson Pharma Corporation Limited Proposes Final Dividend for the Year Ended 31 March 2023, Payable on 1 September 2023	15/06/23	CI
Jacobson Pharma Corporation Limited Reports Earnings Results for the Full Year Ended March 31, 2023	15/06/23	CI
Jacobson Pharma Forecasts 40% Growth in FY23 Profit	01/06/23	MT
Jacobson Pharma Corporation Limited Provides Earning Guidance for the Year Ended 31 March 2023	31/05/23	CI
Jacobson Pharma Boosts Interim Dividend as April-September Profit Increases	28/11/22	MT
Jacobson Pharma Corporation Limited Announces Interim Dividend for the Six Months Ended 30 September 2022, Payable on 29 December 2022	25/11/22	CI
Jacobson Pharma Corporation Limited Reports Earnings Results for the Half Year Ended September 30, 2022	25/11/22	CI
Jacobson Pharma Expects Up to 70% Rise in April-September Profit; Shares Rise 4%	02/11/22	MT
Jacobson Pharma Corporation Limited Provides Earnings Guidance for the Six Months Ended 30 September 2022	02/11/22	CI
Jacobson Pharma Corporation Limited Further Amends Its Facility Agreement	26/10/22	CI
Jacobson Pharma Unit Raises Loan to $10 Million Over Rising Interest Rates	26/10/22	MT
Jacobson Pharma Corporation Limited Approves Final Dividend for the Year Ended 31 March 2022	23/09/22	CI
Jacobson Pharma Unit to Extend Shareholder's Loan	19/07/22	MT
Jacobson Pharma CEO Increases Stake; Shares Rise 3%	12/07/22	MT
Jacobson Pharma Posts Higher FY22 Profit	30/06/22	MT

Chart Jacobson Pharma Corporation Limited

Duration

Period

Chart Jacobson Pharma Corporation Limited

More charts

Company Profile

Jacobson Pharma Corporation Ltd is an investment holding company principally engaged in the manufacturing and sale of generic drugs. The Company operates its business through two segments. The Generic Drugs segment is engaged in the development, manufacture and distribution of a host of off-patent medicines for various therapeutic use. The Branded Healthcare segment is engaged in the development, manufactures and distributes branded medicines, proprietary Chinese medicines and health and wellness products. Currently the activities of two segments in this regard are primarily carried out in Hong Kong.

Sector

Pharmaceuticals

Calendar

21/11/2024 - Q2 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
JACOBSON PHARMA CORPORATION LIMITED	+1.56%	165M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+20.76%	43.77B
OTSUKA HOLDINGS CO., LTD.	+28.00%	22.83B
SANDOZ GROUP AG	+20.25%	15.56B
CIPLA LIMITED	+18.82%	14.34B
ZYDUS LIFESCIENCES LIMITED	+55.83%	12.96B
THE MEDICINES COMPANY	-0.05%	6.79B
ONO PHARMACEUTICAL CO., LTD.	-12.70%	6.41B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+14.65%	5.69B

Generic Pharmaceuticals